Latest imported 13F data

POMDOCTOR LIMITED

(POM)

Financial Statements · SEC EDGAR XBRL

Revenue
$57.2M
EPS
$-3.14
Gross Margin
13.1%
Op. Income
-$17.0M
FCF
-$21.4M
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
$57.2M
-
-
$57.2M
-
-
$49.7M
-
-
$7.5M
-
-
$1.8M
-
-
$24.4M
-
-
-$17.0M
-
-
-$1.8M
-
-
-$18.7M
-
-
$54
-
-
$-3.14
-
-
$-3.14
-
-
9.7M
6.3M
6.3M